Clinical Applications of the Renin-Angiotensin-Aldosterone-Vasopressin Axis in the Horse and Future Directions for Research

Effect of Lactate Minimum Speed-Guided Conditioning on Selected Blood Parameters of Horses

During exercise, equines can suffer severe water and electrolyte imbalances depending on the intensity and duration. In this sense, conditioning aims to promote adaptations to the organism in order to maintain cardiovascular and thermoregulatory stability during exertion. This study aimed to evaluate the effect of conditioning guided by lactate minimum speed (LMS) test on the blood osmolality of horses. We hypothesized that after conditioning the blood osmolality would vary less during exercise and that LMS could be used in equine conditioning program. Ten Arabian horses were evaluated before (ET 1) and after (ET 2) 6 weeks of conditioning. The conditioning intensity was established from the LMS during ET 1. The blood was obtained at rest and during the ETs. An increase in LMS and a decrease in lactate were seen in individual horses; however, these differences were not significant at a group level. No change in blood osmolality was observed when comparing the ETs. The plasma volume remained unchanged in ET 2. The conditioning guided by LMS improved the animals' fitness, which was evidenced by the lower lactate production in ET 2. The fact that the osmolality kept unchanged proves the effectiveness of the osmotic blood balance during exercise, as its control involves the interaction of different systems. Body adaptations occurred with conditioning, providing greater homeostasis control since the plasma volume remained stable in ET 2. It was concluded that the LMS test can be used to define an effective equine conditioning program even though some adjustments are still necessary.

Endocrine and Electrolyte Balances during Periovulatory Period in Cycling Mares

Simple Summary

This study provides new evidence on the physiological mechanisms involved in the electrolyte balance during periovulatory period in cycling mares. The interrelationships among adrenocorticotropic hormone (ACTH), cortisol (CORT), aldosterone (ALD) and electrolytes (sodium—Na⁺, potassium—K⁺ and chloride—Cl⁻) were evaluated. The simultaneous increase in ACTH, CORT and ALD toward the time of ovulation could suggest the involvement of the adrenocortical pituitary axis in the ovulatory mechanisms, contributing at the same time to the maintenance of electrolyte homeostasis.

Abstract

In cycling females, the periovulatory period is characterized by stimulation of the hypothalamic pituitary adrenal (HPA) axis. The aim of present study was to analyze the pattern and interrelationships among adrenocorticotropic hormone (ACTH), cortisol (CORT), aldosterone (ALD) and electrolytes (sodium—Na⁺, potassium—K⁺ and chloride—Cl⁻) during periovulatory period in cycling mares. Venous blood samples were obtained daily from a total of 23 Purebred Spanish broodmares, aged 7.09 ± 2.5 years, from day −5 to day +5 of estrous cycle, considering day 0, the day of ovulation. Plasma ACTH was measured by a fluorescent immunoassay kit, serum CORT and ALD by means of a competitive ELISA immunoassay, and plasma Na⁺, K⁺ and Cl⁻ were quantified by an analyzer with selective electrodes for the three ions. ACTH showed higher concentrations at day 0 compared to days −5 to −1 and +1 to +3 (p < 0.05). CORT showed higher concentrations at day 0 compared to days −5 to −2 and +1 to +5 (p < 0.05). ALD showed higher concentrations at day 0 compared to days −5 to −2 (p < 0.05) and +2 (p < 0.05). Na⁺ and Cl⁻ showed higher concentrations at day 0, compared to day −5 and +5. K⁺ showed lower concentrations at day 0 compared to day +1 (p < 0.05). The significant correlations obtained between ACTH and CORT (r = 0.20) and between ACTH and ALD (r = 0.32) suggest that although ACTH may have an effect both on CORT and ALD, there are other very important determinants that could be considered. Hence, it is possible to presume that the pituitary adrenocortical response and ALD may be involved in the ovulatory mechanisms without a direct relation with electrolyte pattern.

Brain Formaldehyde is Related to Water Intake behavior

A promising strategy for the prevention of Alzheimer’s disease (AD) is the identification of age-related changes that place the brain at risk for the disease. Additionally, AD is associated with chronic dehydration, and one of the significant changes that are known to result in metabolic dysfunction is an increase in the endogenous formaldehyde (FA) level. Here, we demonstrate that the levels of uric formaldehyde in AD patients were markedly increased compared with normal controls. The brain formaldehyde levels of wild-type C57 BL/6 mice increased with age, and these increases were followed by decreases in their drinking frequency and water intake. The serum arginine vasopressin (AVP) concentrations were also maintained at a high level in the 10-month-old mice. An intravenous injection of AVP into the tail induced decreases in the drinking frequency and water intake in the mice, and these decreases were associated with increases in brain formaldehyde levels. An ELISA assay revealed that the AVP injection increased both the protein level and the enzymatic activity of semicarbazide-sensitive amine oxidase (SSAO), which is an enzyme that produces formaldehyde. In contrast, the intraperitoneal injection of formaldehyde increased the serum AVP level by increasing the angiotensin II (ANG II) level, and this change was associated with a marked decrease in water intake behavior. These data suggest that the interaction between formaldehyde and AVP affects the water intake behaviors of mice. Furthermore, the highest concentration of formaldehyde in vivo was observed in the morning. Regular water intake is conducive to eliminating endogenous formaldehyde from the human body, particularly when water is consumed in the morning. Establishing good water intake habits not only effectively eliminates excess formaldehyde and other metabolic products but is also expected to yield valuable approaches to reducing the risk of AD prior to the onset of the disease.